{
  "id": 4,
  "text": "ote off the \n11.4% (USD 2 million, EUR 1.8 million) stake in \nHIL Applied Medical Ltd, an Israelian developer \nof laser-based proton therapy systems. And IBA \ninvested a further EUR 1.6 million in Invest BW, a regional venture capital partner that is \nproviding financing and support to entrepreneurs \nin Walloon Brabant (cf. paragraph 5.5). The participations in affiliated companies (EUR \n129.4 million), contain among others the \nparticipation in the affilated company IBA \nRussia. In paragraph 2.1 we have analyzed the \nimpact of the EU sanctions on the control of IBA \nSA on its Russian subsidiary, and the indicators \nof asset impairment the conflict may raise.",
  "similarity_score": 0.052785275833502475,
  "metadata": {
    "filename": "annual_report_text (1).txt",
    "filepath": "input\\annual_report_text (1).txt",
    "chunk_id": 540,
    "start_char_idx": 0,
    "end_char_idx": 0,
    "page": null,
    "section": null
  }
}